Related Experiment Video
Updated: Feb 26, 2026

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening
Published on: September 5, 2025
The alteration of temoporfin distribution in multicellular tumor spheroids by β-cyclodextrins
Ilya Yakavets1, Igor Yankovsky2, Marie Millard3
1Centre de Recherche en Automatique de Nancy (CRAN), CNRS UMR 7039 (Centre National de la Recherche Scientifique), Université de Lorraine, Campus Sciences, 54500, Vandœuvre-lès-Nancy, France; Institut de Cancérologie de Lorraine, Research Department, Avenue de Bourgogne, 54519, Vandœuvre-lès-Nancy, France; Laboratory of Biophysics and Biotechnology, Physics Faculty, Belarusian State University, 4 Nezavisimosti Av., 220030, Minsk, Belarus.
Abstract:
To be effective anticancer drugs must penetrate tissue efficiently, reaching all target population of cancer cells in a concentration sufficient to exert a therapeutic effect. This study aimed to investigate the ability of methyl-β-cyclodextrin (Me-β-CD) and 2-hydroxypropyl-β-cyclodextrin (Hp-β-CD) to alter the penetration and diffusion of temoporfin (mTHPC) in HT29 multicellular tumor spheroids. mTHPC had а nonhomogenous distribution only on the periphery of spheroids. The presence of β-CDs significantly altered the distribution of mTHPC consisting in the increase of both the depth of photosensitizer penetration and accumulation in HT29 spheroids. We suggest that this improvement is related to the nanoshuttle mechanism of β-CD action, when β-CDs facilitate mTHPC transportation to the cells in the inner layers of spheroids. As a result of mTHPC distribution improvement, β-CDs enhance mTHPC photosensitizing activity towards HT29 multicellular tumor spheroids. The observed effects strongly depend on the type of β-CD. Thus, varying the type of β-CD we can finely tune the possibility of using mTHPC for diagnostic (delimitation of tumor margins) or therapeutic purposes.
Insights
Methyl-β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin enhance temoporfin penetration in tumors. These cyclodextrins improve drug distribution, boosting anticancer efficacy and enabling precise tumor margin delineation.
Area of Science:
- Pharmacology
- Biomedical Engineering
- Cancer Research
Background:
- Anticancer drugs require efficient tissue penetration for therapeutic effect.
- Temoporfin (mTHPC) distribution in tumors is often limited.
- Novel drug delivery systems are needed to improve photosensitizer efficacy.
Purpose of the Study:
- To evaluate methyl-β-cyclodextrin (Me-β-CD) and 2-hydroxypropyl-β-cyclodextrin (Hp-β-CD) effects on temoporfin (mTHPC) penetration and diffusion.
- To assess the impact of cyclodextrins on mTHPC distribution within HT29 multicellular tumor spheroids.
- To determine if cyclodextrins enhance the photosensitizing activity of mTHPC.
Main Methods:
- Utilized HT29 multicellular tumor spheroids as a model system.
- Investigated the distribution of mTHPC with and without Me-β-CD and Hp-β-CD.
- Analyzed changes in mTHPC penetration depth and accumulation within spheroids.
- Assessed the photosensitizing activity of mTHPC following cyclodextrin treatment.
Main Results:
- mTHPC alone showed non-homogenous distribution, primarily on the spheroid periphery.
- Both Me-β-CD and Hp-β-CD significantly increased mTHPC penetration depth and accumulation.
- Cyclodextrins facilitated mTHPC transport to inner tumor spheroid layers via a nanoshuttle mechanism.
- Enhanced mTHPC distribution led to improved photosensitizing activity against HT29 spheroids.
Conclusions:
- Methyl-β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin significantly improve temoporfin penetration and distribution in tumor spheroids.
- Cyclodextrins enhance temoporfin's photosensitizing efficacy through improved cellular uptake.
- The choice of cyclodextrin allows for fine-tuning of temoporfin's application in cancer diagnostics and therapy.

